智通财经APP获悉，周五，Moderna(MRNA.US)盘中一度涨10%，股价创2022年12月以来新高，截至发稿，涨幅收窄至7%，报210.95美元。消息面上，10月9日，Moderna正式纳入纳斯达克100指数，替代华纳兄弟探索。纳入之后，一部分此前不配置生物医药的宽基类机构将被动持有，主动机构亦会把公司放进观察清单，提升个股关注度。
另外，10月7日，公司与默沙东、Tempus扩大多年期合作，为个体化新抗原疗法intismeran autogene的潜在商业化提供肿瘤样本采集、测序及疗法设计和生产支持。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.